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of the remaining 16 patients, 75% returned to normal oral 
intake (median 260 days). Of those that had full conditioning 
treatment (n=31), 22 returned to normal oral intake with a 
mean of 187days. GvHD and duration of PN were correlated 
with return to oral intake. Gender, pre-HSCT oral intake and 
infections were not associated with oral intake. 
Conclusion: Oral intake in young children post HSCT is 
inadequate. PN is required during the period of maximal gut 
toxicity. The majority of these children are NG fed for large 
periods of time prior to resumption of oral intake, and not all 
children return to their normal dietary pattern. 
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Introduction: Haematopoietic Stem Cell Transplant (HSCT), 
knew as Bone Marrow Transplant (BMT), is a life-saving 
therapy for many patients with malignant and non-malignant 
disease, who has no chance of cure a few years ago. Despite 
of this, HSCT, is associated with significant risks of morbidility 
and mortality and it’s always seed as highly stressful even 
under the best circumstances and good cares.  
The HSCT affect directly the patients Quality of Life (QoL). For 
this study, QoL was based on the QoL model for BMT 
Survivors developed by Ferrell and Grant (1992) that depicts 
the QoL domains of physical well-being, psychological well-
being, social concerns and spiritual well-being.  
Methods: We are sure that to improve current nursing practice 
we need to deeply knew HSCT patients QoL. We made an 
exploratory and comparative study between patients 
undergoing HSCT treatment (n=30), patients with mean of 3.2 
years after HSCT, (n=30) and disease free people (n=30) to 
better know their QoL. We matched the tree groups regard to 
age and sex.  
After obtained the informed consent, we ask all the 
participants to fill a questionnaire, assessing some biological 
and socio professional aspects. We also used  a BMT 
Survivors scale, with a high alpha de Cronbach ( >.89), a 
Mental Health Inventory Scale -5 , and a Positive and 
Negative Affect scale. Both disease groups fill the full 
questionnaire and the free disease group fills a questionnaire 
without specifics aspects for BMT patients.  
Results: Results found no statistical differences between the 
three groups. We only found differences between averages: 
for a maxim of 10 points (better QoL) we found 6.4 for the 
inpatient group, 6.1 for the outpatients group and 7 the free 
disease group. QoL is explained for different domains in 
different groups. While spiritual domain score more in the 
diseases groups, the physical domain scored better in the 
disease free group. 
Kneeing the most important QoL domains for each group 
could be a clue to enhance nursing cares.  
Conclusion: Like previous research, we concluded that beside 
the negative impact of HSCT, it has little impact on the QoL 
patients. Patients submitted to HSCT treatment seems to 
have a QoL similar to the disease free group.  HSCT is a 
treatment  full of hope and it represents a second chance to 
live, and that it’s something to get on. 
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In our center from June 2005 to September 2007, 29 patients 
with autoimmune diseases have been treated with an 
autologus bone marrow transplantation: 20 multiple 
sclerosis(MS), 9 systemic sclerosis(SS). Patients affected by 
MS have been treated with BEAM and ATG conditioning, 
while patients with SS with Cyclofosfamide and ATG. The total 
of the days observed is 683 on an average of 22 days of 
recovery. The needs of these patients requested a series of 
organizing and assistance interventions. The first step was 
training all the staff on these two diseases and , after this, we 
have started to evaluate the disability of the MS, before the 
recovery, with the EDDS scale, we have located a suitable 
room, we have removed architectonic barriers and we have 
supplied the ward with useful aids to manage the hypomobility 
of these patients (bed balance, anti decubitus mattress, 
hydraulic power lift). We have seen that MS during the period 
of recovery suffer a drop of their motor capacity with an 
average of days of complete dependence clearly superior to 
the transplanted patients with other pathologies (MS 5,7 gg vs 
SS 0 gg) and we have registered, especially in the aplasia 
phase, an elevated numbers of episodes of diarrhoea 
prolonged in time(4,5 gg with ≥ 3 evacuations a day); for all 
these reasons we have thought essential drawing up an early 
rehabilitative plan in collaboration with physiotherapists. 
In SS chemiotherapy usually improves their autonomy, but the 
pre-existent problems call for a careful monitoring of the 
compromised vital organs function (heart, lungs, kidney) and 
especially the continuous skin control, treating the typical skin 
lesions, present in 8 on 9 patients, and usually are many (until 
9).These brought to a tight collaboration with the 
Rheumatology unit colleagues to draw up the treatment 
procedures and brought a daily heavy commitment of the 
dressings and the pain's management. 
The burden of the assistance for both the patient's type it 
turned out to be superior to the one for patients undergoing an 
autologous transplantation for haematological disease and 
demanded an adjustment of the resources to respond to the 
request. 
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X linked adrenoleukodystrophy (X-ALD) is an inherited 
disorder of very long chain fatty acid metabolism. The 
accumulation of these fatty acids is associated with cerebral 
demyelination, peripheral nerve abnormalities and 
adrenocortical and testicular insufficiency. Bone marrow 
transplant (BMT) performed early has been shown to reverse 
or stabilise abnormalities on cerebral MRI, making timely 
consideration of transplant important.  
We present our experience in transplanting 2 brothers aged 9 
and 7 yrs who were diagnosed simultaneously with X-ALD in 
2006. 
The patients' mother had symptoms of peripheral neuropathy 
and was diagnosed with the milder form of ALD. The maternal 
grandfather was diagnosed with a brain tumour at the same 
time. Genetic family screening then identified the boys and 
they were scanned by MRI. Children with MRI scores (Loes) 
of ≥ 9 have a very poor outcome compared with those with 
